Safety and efficacy of a sucrose-formulated recombinant factor VIII product for the treatment of previously treated patients with haemophilia A in China - Shi,J.; Zhao,Y.; Wu,J.; Sun,J.; Wang,L.; Yang,R. (Haemophilia, 2007)